HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng-Hua Xiong Selected Research

Doxorubicin (Adriamycin)

12/2013Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment.
10/2012Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
5/2011Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng-Hua Xiong Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 07/2010
3Bacterial Infections (Bacterial Infection)
11/2014 - 03/2012
2Infections
11/2014 - 03/2012
1Drug-Related Side Effects and Adverse Reactions
11/2014
1Breast Neoplasms (Breast Cancer)
11/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2014
1Lung Neoplasms (Lung Cancer)
05/2014
1Hepatocellular Carcinoma (Hepatoma)
11/2013
1Liver Diseases (Liver Disease)
03/2013
1Hypoxia (Hypoxemia)
10/2012
1Prostatic Neoplasms (Prostate Cancer)
10/2012

Drug/Important Bio-Agent (IBA)

5Small Interfering RNA (siRNA)IBA
11/2014 - 06/2012
4polyethylene glycol polyethyleneimine nanogelIBA
12/2013 - 03/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2013 - 05/2011
2Anti-Bacterial Agents (Antibiotics)IBA
11/2014 - 03/2012
2Polo-Like Kinase 1IBA
11/2014 - 06/2012
2Ethylene Glycol (Monoethylene Glycol)IBA
10/2012 - 05/2011
2caprolactoneIBA
10/2012 - 03/2012
1PolymersIBA
01/2022
1Biocompatible Materials (Biomaterials)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2021
1AntibodiesIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1Therapeutic UsesIBA
11/2014
1Single-Chain AntibodiesIBA
11/2014
1AntigensIBA
11/2014
1monomethoxypolyethyleneglycol- polylactide block copolymerIBA
11/2014
1ErbB Receptors (EGF Receptor)IBA
05/2014
1Tyrosine Kinase InhibitorsIBA
05/2014
1Transcription Factors (Transcription Factor)IBA
10/2012
1SolutionsIBA
03/2012
1Drug CarriersIBA
03/2012
1Lipase (Acid Lipase)FDA Link
03/2012
1AcidsIBA
05/2011
1GoldIBA
05/2011
1MicellesIBA
07/2010

Therapy/Procedure

7Therapeutics
01/2022 - 10/2012
3Drug Therapy (Chemotherapy)
10/2012 - 07/2010
1Immunotherapy
01/2021
1Intravenous Administration
12/2013